Gynecologic Malignancies

Saturday, May 5, 2018 from 8:45 AM to 9:45 AM
Available for up to 1.00 hours of CPE credit
Activity Number: 0217-9999-18-085-L01-P

Monique D. Giordana, Pharm.D., BCOP

  • Faculty: Monique D. Giordana, Pharm.D., BCOP
    Hematology/Oncology Clinical Pharmacy Specialist, Regions Hospital, Saint Paul, Minnesota
      View Biography

Learning Objectives
1. Design an appropriate patient‐specific treatment, management, and monitoring plan taking into consideration efficacy and safety outcomes of clinical trials and current treatment guidelines for a patient a with a gynecologic malignancy.
2. Discuss short‐ and long‐term goals, including post-therapy and survivorship, with a patient with a gynecologic malignancy and her caregiver.
3. Compare and contrast the efficacy and toxicity of different routes of drug administration, including IP chemotherapy, in the treatment of ovarian cancer.
4. Select relevant information and provide guidance for the public regarding gynecologic malignancy‐related issues (e.g., risk factors, prevention and screening) for gynecologic malignancies.
© 2019 American College of Clinical Pharmacy and American Society of Health‑System Pharmacists